ArticleAIDS (London, England)2019

Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators.

Loveleen Bansi-Matharu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.